Published in PLoS One on December 23, 2009
Evidence of human-to-swine transmission of the pandemic (H1N1) 2009 influenza virus in South Korea. J Clin Microbiol (2010) 1.64
Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus. PLoS One (2010) 1.61
Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults. Clin Infect Dis (2010) 1.52
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev (2012) 1.31
Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination. Clin Vaccine Immunol (2011) 1.02
An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli. PLoS One (2010) 0.97
A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus. PLoS One (2011) 0.96
Infection of swine ex vivo tissues with avian viruses including H7N9 and correlation with glycomic analysis. Influenza Other Respir Viruses (2013) 0.95
Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets. J Virol (2013) 0.91
Pre-existing immunity with high neutralizing activity to 2009 pandemic H1N1 influenza virus in Shanghai population. PLoS One (2013) 0.88
No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009. Emerg Infect Dis (2012) 0.86
Minipigs as an animal model for dermal vaccine delivery. Comp Med (2014) 0.83
Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose. Vaccine (2011) 0.78
Complexities in Ferret Influenza Virus Pathogenesis and Transmission Models. Microbiol Mol Biol Rev (2016) 0.78
Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice. J Gen Virol (2013) 0.77
Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets. PLoS One (2016) 0.75
Vaccines for Pandemic Influenza A H1N1 (2009): Where Do We Stand? Indian J Virol (2010) 0.75
The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36
Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
WWW-query: an on-line retrieval system for biological sequence banks. Biochimie (1996) 11.59
Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep (2009) 9.94
Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 9.06
Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science (2009) 8.61
Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol (1998) 8.44
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science (2009) 7.80
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol (1999) 6.03
Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine (2002) 4.45
Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology (1993) 4.40
Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol (2004) 3.81
New influenza A (H1N1) virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec (2009) 3.79
The ferret: an animal model to study influenza virus. Lab Anim (NY) (2004) 3.75
Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep (2009) 3.43
Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill (2009) 3.30
Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs. J Gen Virol (2009) 3.09
The origin of the recent swine influenza A(H1N1) virus infecting humans. Euro Surveill (2009) 2.69
The use of CLUSTAL W and CLUSTAL X for multiple sequence alignment. Methods Mol Biol (2000) 2.56
The pig as a mixing vessel for influenza viruses: Human and veterinary implications. J Mol Genet Med (2008) 2.35
Influenza A (H1N1) infection in pigs. Vet Rec (2009) 1.63
The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol (1989) 1.62
Swine flu. After delays, WHO agrees: the 2009 pandemic has begun. Science (2009) 1.59
Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. MMWR Morb Mortal Wkly Rep (2009) 1.58
The global agenda on influenza surveillance and control. Vaccine (2003) 1.31
Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks. J Virol (2008) 1.30
Pandemic influenza: the inside story. PLoS Biol (2006) 1.27
Molecular evolution of influenza viruses. Virus Genes (1995) 1.24
Seroprevalence and genetic evolutions of swine influenza viruses under vaccination pressure in Korean swine herds. Virus Res (2008) 1.12
Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets. Vaccine (2009) 0.93
Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab (2005) 7.15
Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem (2006) 2.69
The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe (2013) 1.86
The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model. J Virol (2009) 1.68
Evidence of human-to-swine transmission of the pandemic (H1N1) 2009 influenza virus in South Korea. J Clin Microbiol (2010) 1.64
Highly pathogenic avian influenza virus (H5N1) in domestic poultry and relationship with migratory birds, South Korea. Emerg Infect Dis (2008) 1.48
Continuing evolution of H9 influenza viruses in Korean poultry. Virology (2006) 1.45
Isolation and genetic characterization of H5N2 influenza viruses from pigs in Korea. J Virol (2009) 1.40
Production of omega-3 eicosapentaenoic acid by metabolic engineering of Yarrowia lipolytica. Nat Biotechnol (2013) 1.38
Pak1 protein kinase regulates activation and nuclear localization of Snf1-Gal83 protein kinase. Mol Cell Biol (2004) 1.30
Display of alpha-amylase on the surface of Lactobacillus casei cells by use of the PgsA anchor protein, and production of lactic acid from starch. Appl Environ Microbiol (2006) 1.27
Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation. Cell Host Microbe (2012) 1.16
The GPRLQPY motif located at the carboxy-terminal of the spike protein induces antibodies that neutralize Porcine epidemic diarrhea virus. Virus Res (2007) 1.16
Diet-induced obesity dramatically reduces the efficacy of a 2009 pandemic H1N1 vaccine in a mouse model. J Infect Dis (2011) 1.14
Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses. J Virol (2011) 1.13
Natural and edible biopolymer poly-gamma-glutamic acid: synthesis, production, and applications. Chem Rec (2005) 1.12
Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol (2006) 1.12
Seroprevalence and genetic evolutions of swine influenza viruses under vaccination pressure in Korean swine herds. Virus Res (2008) 1.12
alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J Biol Chem (2003) 1.09
Rapid evolution of low-pathogenic H9N2 avian influenza viruses following poultry vaccination programmes. J Gen Virol (2010) 1.08
Virulence and transmissibility of H1N2 influenza virus in ferrets imply the continuing threat of triple-reassortant swine viruses. Proc Natl Acad Sci U S A (2012) 1.08
Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza. PLoS One (2011) 1.08
Serologic and genetic characterization of North American H3N2 swine influenza A viruses. Can J Vet Res (2007) 1.05
Near-infrared emitting polymer nanogels for efficient sentinel lymph node mapping. ACS Nano (2012) 1.02
Oral administration of high molecular mass poly-gamma-glutamate induces NK cell-mediated antitumor immunity. J Immunol (2007) 1.02
Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination. Clin Vaccine Immunol (2011) 1.02
Identification and characterization of new microRNAs from pig. Mamm Genome (2008) 1.00
Active reassortment of H9 influenza viruses between wild birds and live-poultry markets in Korea. Arch Virol (2009) 0.97
Isolation and characterization of novel H3N1 swine influenza viruses from pigs with respiratory diseases in Korea. J Clin Microbiol (2006) 0.97
Std1p (Msn3p) positively regulates the Snf1 kinase in Saccharomyces cerevisiae. Genetics (2003) 0.96
Complete genome sequence of an avian-origin H3N2 canine influenza virus isolated from dogs in South Korea. J Virol (2012) 0.96
Role of Tos3, a Snf1 protein kinase kinase, during growth of Saccharomyces cerevisiae on nonfermentable carbon sources. Eukaryot Cell (2005) 0.95
Emergence of mammalian species-infectious and -pathogenic avian influenza H6N5 virus with no evidence of adaptation. J Virol (2011) 0.95
AP-1/IRF-3 Targeted Anti-Inflammatory Activity of Andrographolide Isolated from Andrographis paniculata. Evid Based Complement Alternat Med (2013) 0.94
Structure of the Bateman2 domain of yeast Snf4: dimeric association and relevance for AMP binding. Structure (2007) 0.94
Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Int J Cancer (2006) 0.94
Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling. Brain (2012) 0.94
Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine. Vaccine (2012) 0.94
Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets. Vaccine (2009) 0.93
Enzymatic synthesis of high-molecular-mass poly-gamma-glutamate and regulation of its stereochemistry. Appl Environ Microbiol (2004) 0.93
Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect. Cancer Immunol Immunother (2009) 0.92
Identification of a novel one-carbon metabolism regulon in Saccharomyces cerevisiae. J Biol Chem (2003) 0.92
Genetic characterization of avian metapneumovirus subtype C isolated from pheasants in a live bird market. Virus Res (2007) 0.92
Extensive mammalian ancestry of pandemic (H1N1) 2009 virus. Emerg Infect Dis (2010) 0.92
Reversible pulmonary hypertension in adolescent with left atrial myxoma. J Cardiovasc Ultrasound (2011) 0.92
Induction of manganese-containing superoxide dismutase is required for acid tolerance in Vibrio vulnificus. J Bacteriol (2005) 0.92